Stock Report

All about this stock under one free report Last Updated: 03-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Eris Lifesciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: ERIS | BSE: 540596

₹1,288.90

up-down-arrow ₹-11.00 (-0.85%)

As on 02-Sep-2026IST

Market cap

info icon

₹17,919 Cr

Revenue (TTM)

info icon

₹3,230 Cr

P/E Ratio

info icon

27.8

P/B Ratio

info icon

4.4

Div. Yield

info icon

0.6 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 15.42 12.97 9.59 22.59 20.56
EBIT 9.88 8.71 16.84 24.70 16.16
Net Profit -49.44 20.68 69.34 19.69 11.96
EPS -49.47 18.59 64.38 18.46 11.23
Book Value -- -- 10.03 14.19 17.00
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info 24.9027.3726.5824.2524.50
Net Margin info 17.9022.6220.6012.8719.53
Return on equity info 11.6619.3618.7513.8116.64
Return on Capital info 12.5619.23--13.5912.37
Return on Assets info 8.9014.109.265.487.72
Debt to Equity (x) info ----0.240.851.06

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
13.59
12.37
17.30
25.29
Peer Median
--
21.76
21.89
--
17.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

18.75

Higher than Peers by 3.47

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
18.75
13.81
16.64
18.25
23.33
Peer Median
15.28
17.93
16.42
--
17.35
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

9.26

Lower than Peers by 1.04

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
9.26
5.48
7.72
13.40
21.27
Peer Median
10.30
12.81
12.32
--
10.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

26.58

Higher than Peers by 8.76

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
26.58
24.25
24.50
24.90
31.20
Peer Median
17.82
18.93
21.05
--
11.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

20.60

Higher than Peers by 6.23

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
20.60
12.87
19.53
22.06
29.55
Peer Median
14.38
14.94
15.51
--
11.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
23.22
27.41
27.83
33.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

9.59

Lower than Peers by 2.47

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
9.59
44.02
19.23
25.10
11.15
Peer Median
12.07
10.90
13.44
--
11.49
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

16.84

Lower than Peers by 5.11

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
16.84
42.54
17.31
-0.16
8.40
Peer Median
21.96
15.01
23.50
--
-1.10
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

69.34

Higher than Peers by 44.80

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
69.34
-5.65
6.14
-7.79
14.26
Peer Median
24.54
14.80
30.12
--
4.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

64.38

Higher than Peers by 44.11

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
64.38
-10.39
2.58
-5.94
14.23
Peer Median
20.28
14.27
29.02
--
10.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
10.19
17.69
15.04
21.24
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.24

Higher than Peers by 0.24

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
0.24
0.85
1.06
0.38
0.02
Peer Median
0.01
0.06
0.03
--
0.18
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
0.14
0.51
0.03
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.74

Lower than Peers by 1.21

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
0.74
0.89
0.91
1.62
2.51
Peer Median
1.95
1.90
2.23
--
1.72
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.53

Lower than Peers by 0.93

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
0.53
0.67
0.84
1.41
2.16
Peer Median
1.46
1.46
1.59
--
1.41
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

4.45

Lower than Peers by 14.34

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
4.45
3.11
6.09
16.46
105.81
Peer Median
18.79
24.96
45.29
--
24.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

21.07

Lower than Peers by 0.47

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
21.07
15.85
21.00
17.37
11.95
Peer Median
21.54
21.77
20.10
--
23.77
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.45

Lower than Peers by 0.27

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
0.45
0.43
0.41
0.63
0.73
Peer Median
0.72
0.76
0.81
--
1.05
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
54.07
61.68
46.91
39.44
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
32.16
27.66
25.78
27.78
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
140.91
165.04
125.63
155.58
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
--
-54.68
-75.70
-52.94
-88.36
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

27.83

Lower than Peers by 6.14

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
27.83
54.83
29.18
20.36
23.06
Peer Median
33.97
26.81
39.85
--
26.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

4.43

Lower than Peers by 0.37

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
4.43
6.78
4.43
3.55
4.91
Peer Median
4.80
4.65
6.11
--
3.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.56

Higher than Peers by 0.08

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
0.56
0.52
--
1.28
0.87
Peer Median
0.48
0.61
0.37
--
0.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

17.58

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
17.58
20.75
18.29
15.61
18.31
Peer Median
--
27.02
34.57
--
17.31
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

17,919

Lower than Peers by 237

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
Eris Lifesciences
17,919
19,293
11,440
7,779
9,367
Peer Median
18,156
20,914
25,297
--
474
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...